ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma

Tianjin Medical University Second Hospital · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
antineoplastic-agentschemotherapycisplatin
urothelial carcinoma, anlotinib, urogenital neoplasms, cisplatin, carboplatin, gemcitabine, antineoplastic agents, chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 848853
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.